Abstract
Cutaneous adverse drug reactions (CADRs) to systemically administered drugs have increased in number during the last few years. This is due to the expanding number of new active molecules used in the treatment of a variety of diseases. CADRs are varied and described in full detail in oriented manuals of dermatology.
Diagnosis of CADR may be straightforward in some cases but less obvious in some others. The link between the occurrence of a CADR and the systemic administration of a drug (considered to be the culprit agent) is sometimes difficult to assess. The problem is even more complex when several drugs are administrated concomitantly. Several criteria can be taken into account to find the relationship between drug administration and the occurrence of CADRs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Breathnach SM, Hinter H (1992) Adverse drug reactions and the skin. Blackwell Scientific Publications, Oxford
Zürcher K, Krebs A (1992) Cutaneous drug reactions. An integral synopsis of today’s systemic drugs, 2nd edn. Karger, Basel
Pirchler WJ (2007) Drug hypersensitivity. Karger, Basel
Litt JZ (2011) Litt’s drug eruption reference manual, 14th edn. Informa Healthcare, London
Bégaud B, Evreux JC, Jouglard J, Lagier G (1985) Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France. Therapie 40:111–118
Moore N, Paux G, Begaud B, Biour M, Loupi E, Boismare F, Royer RJ (1985) Adverse drug reaction monitoring: doing it the French way. Lancet 2:1056–1058
Friedmann P (2003) Mechanisms in cutaneous drug hypersensitivity. Clin Exp Allergy 33:861–872
Gonçalo M, Bruynzeel D (2011) Patch testing in adverse drug reactions. In: Johansen JD, Frosch PJ, Lepoittevin J-P (eds) Contact dermatitis, 5th edn. Springer, Berlin, pp 475–491
Weedon D (2007) Skin pathology, 2nd edn. Churchill Livingstone, Edinburgh
Barbaud A, Gonçalo M, Bruynzeel D, Bircher A (2001) Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse Drug hypersensitivity reactions. Contact Dermatitis 45:321–328
Barbaud A (2007) Place of drug skin tests. In: Pirchler WJ (ed). Karger, Basel, pp 366–379
Barbaud A (2007) Drug skin tests and systemic cutaneous adverse drug reactions: an update. Expert Rev Dermatol 2:4, www.Future-drugs.com
Barbaud A (2009) Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 29:517–535
Lammintausta K, Kortekangas-Savolainen O (2005) The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 152:968–974
Friedmann PS, Arden-Jones M (2010) Patch testing in drug allergy. Curr Opin Allergy Clin Immunol 10:291–296
Halevy S (2009) Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol 9:322–328
Endo JO, Davis C, Powell PC (2011) The potential utility of patch testing in identifying the causative agent of morbilliform drug eruptions. Dermatitis 22:114–115
Vaillant L, Camenen I, Lorette G (1989) Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol 125:299
Andrade P, Brinca A, Gonçalo M (2011) Patch testing in fixed drug eruptions – a 20-year review. Contact Dermatitis 65:195–201
Santiago F, Gonçalo M, Brites M et al (2008) Drug hypersensitivity syndrome (DRESS): what patch tests can reveal us. Contact Dermatitis 58:S17
Santiago F, Gonçalo M, Vieira R et al (2010) Epicutaneous patch testing in the diagnosis of drug hypersensitivity syndrome (DRESS). Contact Dermatitis 62:47–53
Veien N, Menné T, Maibach HI (2008) Systemic contact-type dermatitis. In: Zhai H, Wilhelm K-P, Maibach HI (eds) Marzulli and Maibach’s dermatotoxicology, 7th edn. CRC, Boca Raton, pp 139–153
Barbaud A (2007) Tests cutanés médicamenteux dans l’exploration des toxideemies. In: Progrès en Dermato-Allergologie. John Libbey Eurotext, Paris, Montrouge, pp 337–351
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lachapelle, JM. (2012). Testing Procedures in Cutaneous Systemic Immune-Related Adverse Drug Reactions. In: Patch Testing and Prick Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25492-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-25492-5_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25491-8
Online ISBN: 978-3-642-25492-5
eBook Packages: MedicineMedicine (R0)